Patent holdings for IPC class G01N 30/50

Total number of patents in this class: 97

10-year publication summary

6
5
9
7
8
5
11
6
3
4
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Shimadzu Corporation
6036
6
Waters Technologies Corporation
1682
6
GE Healthcare Bio-Sciences AB
554
5
Regeneron Pharmaceuticals, Inc.
4019
5
Cytiva Sweden AB
751
4
Bristol-myers Squibb Company
4861
3
Bio-Rad Laboratories, Inc.
1619
3
Quest Diagnostics Investments LLC
376
3
Biotage AB
92
2
Genzyme Corporation
1216
2
Repligen Corporation
265
2
Global Life Sciences Solutions USA LLC
488
2
Cytiva BioProcess R&D AB
302
2
F. Hoffmann-La Roche AG
7951
1
Hoffmann-La Roche Inc.
3280
1
ExxonMobil Research And Engineering Company
2654
1
Merck Patent GmbH
5856
1
Amgen Inc.
3904
1
Hitachi, Ltd.
15247
1
Hitachi High-Technologies Corporation
2017
1
Other owners 45